Patients ( aged @ years ) with acute bacterial skin and skin-structure infections ( cellulitis or erysipelas , major cutaneous abscess , or wound infection ) that had a minimum lesion area of @ cm ( @ ) and were suspected or documented to be associated with a Gram-positive pathogen , were randomly assigned ( @:@ ) , via an interactive voice-response system with block randomisation , to receive intravenous once-daily tedizolid ( @ mg for @ days ) or twice-daily linezolid ( @ mg for @ days ) , with optional oral step-down .